Literature DB >> 16968403

Mycobacterium tuberculosis-susceptible I/St mice develop severe disease following infection with taxonomically distant bacteria, Salmonella enterica and Chlamydia pneumoniae.

L N Nesterenko1, D V Balunets, A S Tomova, J M Romanova, J S Alyapkina, N A Zigangirova, M A Kapina, E V Kondratieva, A V Pichugin, K B Majorov, A S Apt.   

Abstract

Mice of I/St strain develop severe lung inflammation and die shortly following infection with virulent mycobacteria. To find out whether tuberculosis (TB)-susceptible I/St mice are susceptible to other intracellular bacteria, we investigated two different taxonomically distant pathogens, Chlamydia pneumoniae and Salmonella enterica serovar Typhimurium. Comparison of I/St and TB-resistant A/Sn mice (both Nramp1(r)) demonstrated that the former are more susceptible to both salmonella and chlamydia, displaying a significantly shortened survival time following challenge. Lung pathology develops more rapidly in I/St compared to A/Sn mice following infection with chlamydia, despite their similar ability to control bacterial multiplication. Following infection with salmonella, substantial ( approximately 3 log) but very short (second day post-infection) interstrain differences in bacterial loads were observed, accompanied by higher levels of interleukin (IL)-6 and tumour necrosis factor (TNF)-alpha in the peritoneal cavities of I/St mice. I/St macrophages were more permissive for salmonella growth during the first 24 h following infection in vitro. Because the prominent differences in survival time did not correlate with permanent differences in bacterial multiplication, we suggest that both infections trigger fatal pathological processes whose dynamics depend strongly upon the host genetics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16968403      PMCID: PMC1809730          DOI: 10.1111/j.1365-2249.2006.03184.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

Review 1.  Immunity to intracellular pathogens as a complex genetic trait.

Authors:  Igor Kramnik; Victor Boyartchuk
Journal:  Curr Opin Microbiol       Date:  2002-02       Impact factor: 7.934

2.  Ethnic-specific genetic associations with pulmonary tuberculosis.

Authors:  Julio C Delgado; Andres Baena; Sok Thim; Anne E Goldfeld
Journal:  J Infect Dis       Date:  2002-10-16       Impact factor: 5.226

3.  Multigenic control of Listeria monocytogenes susceptibility in mice.

Authors:  V L Boyartchuk; K W Broman; R E Mosher; S E D'Orazio; M N Starnbach; W F Dietrich
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

Review 4.  The battle of two genomes: genetics of bacterial host/pathogen interactions in mice.

Authors:  A Lengeling; K Pfeffer; R Balling
Journal:  Mamm Genome       Date:  2001-04       Impact factor: 2.957

5.  Comparative analysis of mycobacterial infections in susceptible I/St and resistant A/Sn inbred mice.

Authors:  B V Nikonenko; M M Averbakh; C Lavebratt; E Schurr; A S Apt
Journal:  Tuber Lung Dis       Date:  2000

6.  Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis.

Authors:  Agnes A Awomoyi; Arnaud Marchant; Joanna M M Howson; Keith P W J McAdam; Jenefer M Blackwell; Melanie J Newport
Journal:  J Infect Dis       Date:  2002-11-22       Impact factor: 5.226

7.  Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma.

Authors:  Antonio Gigliotti Rothfuchs; Maria Regina Kreuger; Hans Wigzell; Martin E Rottenberg
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

8.  Multigenic control of disease severity after virulent Mycobacterium tuberculosis infection in mice.

Authors:  Fabio Sánchez; Tatiana V Radaeva; Boris V Nikonenko; Ann-Sophie Persson; Selim Sengul; Martin Schalling; Erwin Schurr; Alexander S Apt; Catharina Lavebratt
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Lung cell responses to M. tuberculosis in genetically susceptible and resistant mice following intratracheal challenge.

Authors:  E B Eruslanov; K B Majorov; M O Orlova; V V Mischenko; T K Kondratieva; A S Apt; I V Lyadova
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

10.  Different innate ability of I/St and A/Sn mice to combat virulent Mycobacterium tuberculosis: phenotypes expressed in lung and extrapulmonary macrophages.

Authors:  Konstantin B Majorov; Irina V Lyadova; Tatiana K Kondratieva; Eugeny B Eruslanov; Elvira I Rubakova; Marianna O Orlova; Vladimir V Mischenko; Alexander S Apt
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

View more
  4 in total

1.  Tuberculosis and the risk of infection with other intracellular bacteria: a population-based study.

Authors:  M A Huaman; C T Fiske; T F Jones; J Warkentin; B E Shepherd; L A Ingram; F Maruri; T R Sterling
Journal:  Epidemiol Infect       Date:  2014-08-22       Impact factor: 2.451

2.  A small-molecule compound belonging to a class of 2,4-disubstituted 1,3,4-thiadiazine-5-ones suppresses Salmonella infection in vivo.

Authors:  Ludmila N Nesterenko; Nailya A Zigangirova; Egor S Zayakin; Sergey I Luyksaar; Natalie V Kobets; Denis V Balunets; Ludmila A Shabalina; Tatiana N Bolshakova; Olga Y Dobrynina; Alexander L Gintsburg
Journal:  J Antibiot (Tokyo)       Date:  2016-01-06       Impact factor: 2.649

3.  I/St mice hypersusceptible to Mycobacterium tuberculosis are resistant to M. avium.

Authors:  E V Kondratieva; V V Evstifeev; T K Kondratieva; S N Petrovskaya; A V Pichugin; E I Rubakova; M M Averbakh; A S Apt
Journal:  Infect Immun       Date:  2007-07-30       Impact factor: 3.441

4.  Coinfection is an important factor in epidemiological studies: the first serosurvey of the aoudad (Ammotragus lervia).

Authors:  M G Candela; E Serrano; C Martinez-Carrasco; P Martín-Atance; M J Cubero; F Alonso; L Leon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-20       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.